
Vesimycin 10mg Injection
Marketer
Naprod Life Sciences
Salt Composition
Mitomycin (10mg)
Overview Vesimycin 10mg Injection
Pancrease, breast, lung, and stomach cancers may be treated with the intravenous medication, Oncosyn 10mg. This agent, administered solely or within a combined chemotherapy regimen, inhibits cancerous cell proliferation, ultimately leading to their demise. Oncosyn 10mg is administered intravenously under strict medical supervision; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere precisely to your doctor's instructions; improper usage or overdose can result in severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only upon your doctor's instruction. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting. Report any concerning symptoms to your physician; mitigation strategies may be available. Prior to treatment, disclose any pre-existing blood, kidney, liver, or respiratory conditions. Oncosyn 10mg lowers blood cell counts, increasing infection susceptibility. Regular blood tests monitoring blood cell levels, as well as kidney, liver, and cardiac function, are essential. To prevent conception, both partners should employ reliable contraception throughout the treatment period.
Primary Ingredients of Vesimycin 10mg Injection
The provided text is "undefined," so no rephrasing is possible.
Uses of Vesimycin 10mg Injection
Malignancies of the pancreas, breast, lung (non-small cell), and stomach.
Major Benefits of Vesimycin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vesimycin 10mg Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Vesimycin 10mg Injection:
This medication will be administered by your healthcare provider; please do not self-medicate.
How Vesimycin 10mg Injection works:
OncoVycin 10mg Injection, an antineoplastic agent, inhibits cancer cell proliferation by targeting and disrupting their DNA, thereby halting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Vesimycin 10mg Injection and alcohol may result in pronounced somnolence.
PregnancyUNSAFE
Administering Vesimycin 10mg Injection to pregnant individuals poses a considerable risk. Pregnant women should consult their physician; research in animal and human studies indicates substantial harm to the fetus.
Breast feedingCAUTION
The administration of Vesimycin 10mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vesimycin 10mg Injection might induce adverse reactions that compromise driving capabilities. Nausea and vomiting, potential side effects of Vesimycin 10mg Injection, can significantly slow reflexes, rendering safe vehicle operation difficult.
KidneyCAUTION
Caution is advised when administering Vesimycin 10mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is recommended. Vesimycin 10mg Injection is contraindicated in patients exhibiting end-stage renal disease.
LiverCAUTION
Administering Vesimycin 10mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Vesimycin 10mg Injection might be necessary. Physician consultation is advised. Vesimycin 10mg Injection may be contraindicated for certain patients exhibiting liver dysfunction.
What if you forget to take Vesimycin 10mg Injection :
NA
Facts to Know About Vesimycin 10mg Injection
| Label | Value |
|---|---|
| Chemical Category | Cancer-Fighting Antibiotics |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Cytotoxic alkaloids |
